IMAY
IS NOT YET AVAILABLE FOR TRADING. CLICK THE TICKER TO VIEW THE FUND'S SEC FILING. INFORMATION CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT. A REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION BUT HAS NOT YET BECOME EFFECTIVE. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION STATEMENT BECOMES EFFECTIVE. THIS COMMUNICATION SHALL NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER SECURITIES LAWS OF ANY SUCH STATE. AN INDICATION OF INTEREST IN RESPONSE TO THIS ADVERTISEMENT WILL INVOLVE NO OBLIGATION OR COMMITMENT OF ANY KIND.
1. The estimated average cap and distribution rate are illustrated by the funds' strategy, based upon the 5 previous trading days, as of 4/23/2024. It does not represent the actual cap that will be set on the date of rebalance, which may fall outside the stated cap ranges, due to extreme market volatility.
2. The estimated distribution rate ranges and cap ranges are based on the highest and lowest Cap as illustrated by the Funds' strategy from 3/22/2024 - 4/22/2024 and are shown gross of the fund's management fee.
3. The estimated cap range is based on the 21 trading days prior to April 16th and is shown gross of the fund's management fee.
The cap and defined distribution rate for each Fund will be set at the beginning of the Outcome Period, and is dependent upon market conditions at that time. Periods of high market volatility could result in higher values, and lower volatility could result in lower values.
Upside/downside refers to the fund's upside and downside participation levels, to a cap, of the reference asset.
There is no guarantee the funds will achieve their investment objectives. The funds have characteristics unlike other traditional investment products and may not be suitable for all investors. Please see "investor suitability" in the prospectus. Shares purchased after the start of an outcome period may be subject to enhanced risks.